Solve Therapeutics
PrivateLast Round
VC Round
Nov 17, 2025
Total Funding Raised
$126M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Solve Therapeutics is a clinical-stage biotechnology company developing antibody-drug conjugates (ADCs) and a novel diagnostic platform for solid tumor malignancies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Solve Therapeutics Comparables
Compare Solve Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Adcentrx Therapeutics | 88% | |
| Ona Therapeutics | 83% | |
| Duality Biotherapeutics Inc | 77% | |
Solve Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Nov 17, 2025 | ||||
| VC Round | Dec 26, 2024 | ||||
| Series A | Dec 14, 2022 |
Solve Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Surveyor Capital | VC Round, Series A |
| SymBiosis Capital Management | VC Round |
| Balyasny Asset Management L.P. | VC Round |
| B Capital Group | VC Round |
| Ally Bridge Group | VC Round |
| DC Ventures | VC Round |
| Abingworth | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 17, 2025
$120M raised in early funding.
- Dec 26, 2024
$75M raised with participation from General Atlantic and Citadel.
Solve Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Solve Therapeutics's valuation, stock price, and market status.